Related references
Note: Only part of the references are listed.Codon-specific translation reprogramming promotes resistance to targeted therapy
Francesca Rapino et al.
NATURE (2018)
Glycogen storage disease type Ia mice with less than 2% of normal hepatic glucose-6-phosphatase-α activity restored are at risk of developing hepatic tumors
Goo-Young Kim et al.
MOLECULAR GENETICS AND METABOLISM (2017)
Downregulation of SIRT1 signaling underlies hepatic autophagy impairment in glycogen storage disease type Ia
Jun-Ho Cho et al.
PLOS GENETICS (2017)
Codon identity regulates mRNA stability and translation efficiency during the maternal-to-zygotic transition
Ariel A. Bazzini et al.
EMBO JOURNAL (2016)
Analysis of protein-coding genetic variation in 60,706 humans
Monkol Lek et al.
NATURE (2016)
Mice expressing reduced levels of hepatic glucose-6-phosphatase-α activity do not develop age-related insulin resistance or obesity
Goo-Young Kim et al.
HUMAN MOLECULAR GENETICS (2015)
Codon optimization of genes for efficient protein expression in mammalian cells by selection of only preferred human codons
Satoshi Inouye et al.
PROTEIN EXPRESSION AND PURIFICATION (2015)
Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics
Priya S. Kishnani et al.
GENETICS IN MEDICINE (2014)
A critical analysis of codon optimization in human therapeutics
Vincent P. Mauro et al.
TRENDS IN MOLECULAR MEDICINE (2014)
The upstream enhancer elements of the G6PC promoter are critical for optimal G6PC expression in murine glycogen storage disease type Ia
Young Mok Lee et al.
MOLECULAR GENETICS AND METABOLISM (2013)
Exonic Transcription Factor Binding Directs Codon Choice and Affects Protein Evolution
Andrew B. Stergachis et al.
SCIENCE (2013)
Prevention of hepatocellular adenoma and correction of metabolic abnormalities in murine glycogen storage disease type Ia by gene therapy
Young Mok Lee et al.
HEPATOLOGY (2012)
Long-Term Efficacy Following Readministration of an Adeno-Associated Virus Vector in Dogs with Glycogen Storage Disease Type Ia
Amanda Demaster et al.
HUMAN GENE THERAPY (2012)
Recombinant AAV-directed gene therapy for type I glycogen storage diseases
Janice Y. Chou et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2011)
Adeno-Associated Virus-Mediated Correction of a Canine Model of Glycogen Storage Disease Type Ia
David A. Weinstein et al.
HUMAN GENE THERAPY (2010)
Complete Normalization of Hepatic G6PC Deficiency in Murine Glycogen Storage Disease Type Ia Using Gene Therapy
Wai Han Yiu et al.
MOLECULAR THERAPY (2010)
Glycogen storage disease type I and G6Pase-β deficiency: etiology and therapy
Janice Y. Chou et al.
NATURE REVIEWS ENDOCRINOLOGY (2010)
The Role of Thiols and Disulfides on Protein Stability
Maulik V. Trivedi et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2009)
The molecular basis of glycogen storage disease type 1a
JJ Shieh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Share Paper
